{"ticker": {"uuid": "2bd8dbb6-3b42-4d18-91e3-d6ee11c7d944", "symbol": "AVNS", "name": "Avanos Medical Inc", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "Avanos to supplement proxy after shareholder suits; J.P. Morgan valuation range cited", "summary": "Avanos will voluntarily supplement its definitive proxy statement due to shareholder lawsuits alleging disclosure deficiencies related to its pending $25.00-per-share merger. The company denies the allegations, stating the supplement aims to avoid litigation delays and costs, wit", "url": "https://www.tradingview.com/news/tradingview:da4dca19c1ae3:0-avanos-to-supplement-proxy-after-shareholder-suits-j-p-morgan-valuation-range-cited/", "source_name": "TradingView", "published_at": "2026-07-15T09:47:32", "published_display": "15 Jul 2026 09:47", "sentiment": "negative", "sentiment_pct": 38, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Avanos Medical, Inc. \u2013 MUN:8HH", "summary": "This article displays the \"Price to earnings forward\" metric for Avanos Medical, Inc. (MUN:8HH) on the TradingView platform. The content primarily shows navigation and interface elements of the TradingView site, with the specific financial data point itself being \"Period Value Ch", "url": "https://www.tradingview.com/symbols/MUN-8HH/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-10T06:09:21", "published_display": "10 Jul 2026 06:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Latham Advises on Financing for American Industrial Partners\u2019 US$1.272 Billion Acquisition of Avanos Medical, Inc.", "summary": "Latham & Watkins LLP represented the financing sources for American Industrial Partners' (AIP) acquisition of Avanos Medical, Inc., a medical technology company. AIP acquired Avanos in an all-cash transaction valued at approximately US$1.272 billion. The Latham team involved part", "url": "https://www.lw.com/en/news/2026/07/latham-advises-on-financing-for-american-industrial-partners-acquisition-of-avanos-medical-inc", "source_name": "Latham & Watkins LLP", "published_at": "2026-07-09T00:10:38", "published_display": "09 Jul 2026 00:10", "sentiment": "positive", "sentiment_pct": 70, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Has Avanos Medical (AVNS) Run Ahead Of Fundamentals On Its Russell Index Removal?", "summary": "Avanos Medical (AVNS) was recently removed from the Russell 2000 Defensive and Value-Defensive Indexes, which can impact institutional trading. Despite this, AVNS has seen significant recent share price gains of 79.02% over 90 days and 122.90% year-to-date. The article questions ", "url": "https://simplywall.st/stocks/us/healthcare/nyse-avns/avanos-medical/news/has-avanos-medical-avns-run-ahead-of-fundamentals-on-its-rus", "source_name": "Simply Wall Street", "published_at": "2026-07-09T00:10:17", "published_display": "09 Jul 2026 00:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos Medical (AVNS) Q4 2024 earnings summary", "summary": "Avanos Medical (AVNS) reported strong Q4 and full-year 2024 performance, driven by growth in Enteral Feeding and the divestiture of its respiratory health business. Despite a net loss due to a non-cash impairment charge, the company achieved significant increases in adjusted dilu", "url": "https://quartr.com/events/avanos-medical-inc-avns-q4-2024_on8vL18K", "source_name": "Quartr", "published_at": "2026-07-08T13:11:14", "published_display": "08 Jul 2026 13:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Avanos Medical, Inc. \u2013 LS:A2JNRG", "summary": "This article provides financial data for Avanos Medical, Inc. (LS:A2JNRG) focusing on its Enterprise Value to EBIT forward ratio. It highlights the availability of financial figures and market data for the company through TradingView, noting that the market is currently closed.", "url": "https://www.tradingview.com/symbols/LS-A2JNRG/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-07-07T15:39:55", "published_display": "07 Jul 2026 15:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos Medical (AVNS) Q1 2026 earnings summary", "summary": "Avanos Medical announced its Q1 2026 earnings, reporting net sales of $182.2 million, an 8.8% increase year-over-year, driven by strong growth in Specialty Nutrition Systems. The company also announced a definitive agreement to be acquired by affiliates of American Industrial Par", "url": "https://quartr.com/events/avanos-medical-inc-avns-q1-2026_on8v3hZe", "source_name": "Quartr", "published_at": "2026-07-07T12:09:21", "published_display": "07 Jul 2026 12:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Avanos Medical, Inc. \u2013 LS:A2JNRG", "summary": "This article focuses on the enterprise value to revenue forward for Avanos Medical, Inc. (LS:A2JNRG). It appears to be a financial data point from TradingView, indicating a key valuation metric for the company. The content primarily highlights this specific financial metric witho", "url": "https://www.tradingview.com/symbols/LS-A2JNRG/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-07T10:10:54", "published_display": "07 Jul 2026 10:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos stock stays tied to medical devices.", "summary": "Avanos Medical Inc (ISIN US05350V1061) is a Nasdaq-listed medical device company specializing in chronic care, pain management, and digestive health products. The company's business model relies on its portfolio of infection prevention, chronic care, and interventional products, ", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/avanos-stock-stays-tied-to-medical-devices/69707128", "source_name": "AD HOC NEWS", "published_at": "2026-07-06T16:10:34", "published_display": "06 Jul 2026 16:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos Medical advances toward AIP-led go-private merger", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxQNWJyc2xEZXdDZXRHamJ6eGhiNXNzcHAzeGViUDAyVnd1TmNycTcyWXc1emQya0d4SmhMMkt4TTNwQVB6LXVOal81RE1ZRUJNNDduai1iV3F1OE83ajdtWXdSZ2NPSnFPSmt1Q1B0bnpobzdVcEpKcGQ3UE5RNGtwVkpOalJMWjVTcHc2S05OZWJkSjdHTHZyS3BqZ0ptblF4bnlSS0VYRzJPUzFSYTliT3N2MDUwZFRWNzdWRFBpWlVYTy0tSzVuSTl3LUQtSTFPcGdn?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-07-03T14:42:00+00:00", "published_display": "03 Jul 2026 14:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos, American Industrial Get Regulatory Approval for Merger", "summary": "Avanos and American Industrial have received regulatory approval for their merger. This development marks a significant step forward for the two companies as they proceed with their integration plans.", "url": "https://www.moomoo.com/news/post/72407474/avanos-american-industrial-get-regulatory-approval-for-merger", "source_name": "Moomoo", "published_at": "2026-07-03T10:10:05", "published_display": "03 Jul 2026 10:10", "sentiment": "positive", "sentiment_pct": 71, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVANOS MEDICAL INC (AVNS) Stock Chart", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZEFVX3lxTE5LUHI0Uk9uZzJ0N3JvdTJLc3BiMnlLT1RtRE5laXdRZjBjX1JKUDFJSDRaZzl6UTBsU281ck5rSE5mczN1cGMyUlBtZEpQTzRqN09xUjNVaVhucENkVnhWX2N5NDg?oc=5", "source_name": "ChartMill", "published_at": "2026-07-03T00:18:39+00:00", "published_display": "03 Jul 2026 00:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos Medical, Inc. and American Industrial Partners Receive Required Regulatory Approvals for Pending Merger", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/avanos-medical-inc-american-industrial-140000118.html", "source_name": "PR Newswire", "published_at": "2026-07-02T14:00:00+00:00", "published_display": "02 Jul 2026 14:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos Medical, American Industrial Partners Clear Regulatory Hurdle for Merger", "summary": "Avanos Medical Inc. and American Industrial Partners (AIP) have received all necessary regulatory approvals for AIP's acquisition of Avanos Medical, moving the deal closer to its projected completion later this month. The merger, valued at approximately $2.2 billion, is now subje", "url": "https://www.citybiz.co/article/869447/avanos-medical-american-industrial-partners-clear-regulatory-hurdle-for-merger/", "source_name": "citybiz", "published_at": "2026-07-02T14:39:26", "published_display": "02 Jul 2026 14:39", "sentiment": "positive", "sentiment_pct": 71, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 96, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos receives regulatory approvals, merger expected to close by July 27 pending shareholder vote", "summary": "Avanos (AVNS) has secured all necessary regulatory approvals for its acquisition by affiliates of American Industrial Partners. The merger is anticipated to finalize by July 27, 2026, contingent on shareholder approval. A special stockholder meeting for Avanos to vote on the merg", "url": "https://www.tradingview.com/news/tradingview:6de122e513bd7:0-avanos-receives-regulatory-approvals-merger-expected-to-close-by-july-27-pending-shareholder-vote/", "source_name": "TradingView", "published_at": "2026-07-02T14:39:26", "published_display": "02 Jul 2026 14:39", "sentiment": "positive", "sentiment_pct": 67, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 96, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos Medical stock holds its focus on procedure demand", "summary": "Avanos Medical (AVNS) focuses on procedure demand within its US medtech footprint, with its stock performance tied to hospital and outpatient spending trends. The company, which trades on the NYSE, specializes in products for pain management, digestive health, and respiratory car", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/avanos-medical-stock-holds-its-focus-on-procedure-demand/69672323", "source_name": "AD HOC NEWS", "published_at": "2026-07-02T11:39:26", "published_display": "02 Jul 2026 11:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Avanos Medical (AVNS) Undervalued Or Has Its Strong Run Already Priced In?", "summary": "Avanos Medical (AVNS) has seen significant stock performance despite recent net losses and declining longer-term returns. The company's current Price-to-Sales (P/S) multiple of 1.6x is below industry and peer averages, suggesting a discount, but is above an estimated fair P/S rat", "url": "https://www.sahmcapital.com/news/content/is-avanos-medical-avns-undervalued-or-has-its-strong-run-already-priced-in-2026-06-30", "source_name": "Sahm", "published_at": "2026-07-01T22:40:44", "published_display": "01 Jul 2026 22:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Avanos Medical, Inc. \u2013 LS:A2JNRG", "summary": "This article displays the forward price-to-sales ratio for Avanos Medical, Inc. (LS:A2JNRG) on TradingView. It indicates that the market was closed at the time of viewing, with no trades having occurred. The page provides an overview of financial data for the company.", "url": "https://www.tradingview.com/symbols/LS-A2JNRG/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-01T08:09:46", "published_display": "01 Jul 2026 08:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos Medical with steady outlook, shares tracked against medtech peers", "summary": "Avanos Medical is focused on single-use medical devices and is situated within a consolidating medtech sector, with its shares tracked against competitors like Medtronic and Boston Scientific. Analysts generally hold a moderate upside view on AVNS shares, focusing on the company'", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/avanos-medical-with-steady-outlook-shares-tracked-against-medtech-peers/69655500", "source_name": "AD HOC NEWS", "published_at": "2026-06-29T20:41:09", "published_display": "29 Jun 2026 20:41", "sentiment": "positive", "sentiment_pct": 60, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos Medical, Inc.(NYSE: AVNS) dropped from Russell 2000 Defensive Index", "summary": "Avanos Medical, Inc. (NYSE: AVNS) has been removed from the Russell 2000 Defensive Index. This news follows several recent updates for the company, including first-quarter earnings results and an announcement of its acquisition by American Industrial Partners for $1.27 billion. A", "url": "https://www.marketscreener.com/news/avanos-medical-inc-nyse-avns-dropped-from-russell-2000-defensive-index-ce7f5fded881f424", "source_name": "www.marketscreener.com", "published_at": "2026-06-28T20:52:03", "published_display": "28 Jun 2026 20:52", "sentiment": "negative", "sentiment_pct": 39, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos Medical, Inc. Actuals & Estimates (NYSE:AVNS)", "summary": "This article provides an overview of Avanos Medical, Inc. (NYSE:AVNS) stock's financial performance, including actuals and estimates for income, balance sheet, and cash flow. It details current stock price, historical highs and lows, market capitalization, and upcoming earnings r", "url": "https://www.tradingview.com/symbols/NYSE-AVNS/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T12:40:58", "published_display": "26 Jun 2026 12:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVNS - Avanos Medical Inc Latest SEC Filings", "summary": "This article provides detailed financial data and market performance metrics for Avanos Medical Inc (AVNS), including its stock price, market capitalization, income, sales, and various financial ratios. It also lists key dates, such as IPO and earnings, along with insider and ins", "url": "https://finviz.com/stock?t=AVNS&ta=1&p=d&ty=lf&b=1", "source_name": "Finviz", "published_at": "2026-06-25T21:39:26", "published_display": "25 Jun 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Avanos Medical, Inc. \u2013 BOATS:AVNS", "summary": "This article provides the \"Price to earnings forward\" metric for Avanos Medical, Inc. (AVNS) on the Blue Ocean Alternative Trade System (BOATS) platform. It indicates that the market is closed, with no trades currently available for the stock. The content is primarily a listing o", "url": "https://www.tradingview.com/symbols/BOATS-AVNS/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T15:10:58", "published_display": "25 Jun 2026 15:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spotting Winners: Merit Medical Systems (NASDAQ:MMSI) And Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks In Q1", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPZ3VmWDdGZC04R2RXUUJZTHJqVlJrdnhJYy1LaEJkcHBaWi1sWXdoWS1oLWFlVUQxdFNOQlNDdzhaTHJtMGRkX3pHc1pWbGp0bENwY1h6TlpvWVRWWmJxODh4emhGVDBFajd0VWNmUGNVcnN1SDBXRG9jZFVDa2M4MGFCVFhxbGN0ZXZqSTV2SUE1S3JjMTRnQlBiSnVmR0lv?oc=5", "source_name": "Market source", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price-Driven Insight from (AVNS) for Rule-Based Strategy", "summary": "This article provides a price-driven insight into Avanos Medical Inc. (AVNS) for rule-based trading strategies. It highlights neutral near and mid-term readings but a strong long-term positive bias, noting that resistance is being tested. The analysis details institutional tradin", "url": "https://news.stocktradersdaily.com/news_release/101/Price-Driven_Insight_from_AVNS_for_Rule-Based_Strategy_062426104202_1782355322.html", "source_name": "Stock Traders Daily", "published_at": "2026-06-24T22:42:00", "published_display": "24 Jun 2026 22:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos Medical Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avanos Medical, Inc. - AVNS", "summary": "Kahn Swick & Foti, LLC (KSF) is investigating the proposed sale of Avanos Medical, Inc. (NYSE: AVNS) to affiliates of American Industrial Partners. KSF is scrutinizing the $25.00 per share cash offer to determine if it adequately values the company and if the sales process was fa", "url": "https://www.businesswire.com/news/home/20260624050462/en/Avanos-Medical-Investor-Alert-Kahn-Swick-Foti-LLC-Investigates-Adequacy-of-Price-and-Process-in-Proposed-Sale-of-Avanos-Medical-Inc.---AVNS", "source_name": "Business Wire", "published_at": "2026-06-24T19:09:49", "published_display": "24 Jun 2026 19:09", "sentiment": "negative", "sentiment_pct": 37, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reasons to Retain Avanos Medical Stock in Your Portfolio for Now", "summary": "Avanos Medical (AVNS) is well-positioned for growth due to its strong product line, particularly in Specialty Nutrition Systems, and strategic acquisitions like Nexus Medical, despite challenges from tariff risks and weaknesses in its Pain Management & Recovery business. The comp", "url": "https://uk.finance.yahoo.com/news/reasons-retain-avanos-medical-stock-134700828.html", "source_name": "Market source", "published_at": "2026-06-24T13:47:00", "published_display": "24 Jun 2026 13:47", "sentiment": "positive", "sentiment_pct": 61, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos Medical Inc (AVNS) Institutional Confidence", "summary": "Avanos Medical Inc (AVNS) has an institutional shareholding score of 10.00, placing it first in the Healthcare Equipment & Supplies industry. This score reflects a 97.19% institutional shareholding proportion, although this represents a 14.66% decrease quarter-over-quarter. Diamo", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-avns/sentiment", "source_name": "TradingKey", "published_at": "2026-06-24T06:39:47", "published_display": "24 Jun 2026 06:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Undervalued Medical-Devices Stock Is Poised for a Rebound", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPN1g2RjVsUTVvTmdXRTdJMTRpVTlOQnZIbm9hTWJDdkRaeVpINjFqbXpDUVFpMVdYMExyR2VQQVNpZ3p0V2F1SVJMelpJZWk1bExvb0dYWnJ4VVJJRURseEVQVVZwNnRZREZiQzlFTHlhSHFadGdXRmpxbXA2XzBMNA?oc=5", "source_name": "Barron's", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos Medical Stock - Long-term strategy in focus for medtech specialist", "summary": "Avanos Medical focuses on single-use medical devices for pain management and minimally invasive care. The article highlights the company's long-term strategy, portfolio mix, and market positioning against larger medtech competitors. It also discusses Avanos's revenue drivers, cap", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/avanos-medical-stock-long-term-strategy-in-focus-for-medtech-specialist/69592941", "source_name": "AD HOC NEWS", "published_at": "2026-06-20T19:10:37", "published_display": "20 Jun 2026 19:10", "sentiment": "positive", "sentiment_pct": 63, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos Medical Inc (AVNS) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "Avanos Medical Inc (AVNS) has an earnings forecast score of 6.00, placing it 172nd in its industry, with an average analyst price target of $14.00. One analyst currently rates the stock as \"Hold\". The company's expected revenue for the next quarter is $173.00 million, and its EPS", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-avns/earnings", "source_name": "TradingKey", "published_at": "2026-06-18T09:10:34", "published_display": "18 Jun 2026 09:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos Medical Inc (AVNS) Financial Health: Profitability & Balance Sheet Analysis", "summary": "Avanos Medical Inc (AVNS) has a strong financial health score of 7.17, ranking 104 out of 204 in its industry. The company demonstrated robust operating efficiency with a year-over-year revenue increase of 8.78% to $182.20M and a net profit increase of 22.73%. This analysis highl", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-avns/financial-health", "source_name": "TradingKey", "published_at": "2026-06-17T22:10:35", "published_display": "17 Jun 2026 22:10", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spotting Winners: Enovis (NYSE:ENOV) And Medical Devices & Supplies - Specialty Stocks In Q1", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQRWNsVUM3aGV5UmJHYUowOWtNRU11RzZSalpyampRQ3ZQTlBNV05zSHo4MTJJS0JqTV92LWV3MUdXWkRIckNNZi1aeVg1TmtKNFpoS3g5dTBXRW1BZXRMWGo1SVl2NjNaQ2NSNV90V0MtMzBEQndVclZzUUVXbi1FU0lyU0FndlAwaXNfUVpOTXBEZWQtQVpmanRoU0JjLWxlakFJSQ?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At Avanos Medical (AVNS) Valuation After Recent 3 Month Share Price Surge", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNdXpRaVFkdXV4UlhHbFBUcS1BYTdqS3lzY1d3QnZzNTJWNGs5ZWQ5Mm9fUi1mYUlib3BvQ3I5cV9hNE1yQXViOGpWeE83QkhDY3cwaExjU2hTOTExN01QRHRMV0tvODQ4cVN0NWNVM3BGdFlhcFdxaWp3bWtGaFh3c0dlQ2V6MTE3cmVGTVhTbTJ3Y01aQmFTRDVkMXRpZjA4?oc=5", "source_name": "Market source", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos Medical (AVNS) Up 1.1% Since Last Earnings Report: Can It Continue?", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxNakY5bm9uT1lVNGNfX2lUZXc1cHBNZUlzWXgycGpmXzRMOTVJVEhnbHZ5VzRFd3FBS0pHSm0yZjJVZU5HWlNTR1V1THJVQnpXUi01Yi1PNFhRVF80VzVOQlY1TzRlcXFGcWxPWlhnQy15N3VEMDhnMVlXZUN2Q1ZMVUtGMnN2dzRzNmxBa1lEMU1Pdw?oc=5", "source_name": "Market source", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spotting Winners: Boston Scientific (NYSE:BSX) And Medical Devices & Supplies - Diversified Stocks In Q1", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQV2pTUXRCTjY5SmdHMUhoekd1YmdUMW44R1VVYVlZZzh6QzB1VDZqSzJXT1RLOWpZeE16cGVfaVU3bUFsZ0g5OUkyRlpmQjUxUGw0eDAyb3oySURyM2taYm5qeWZRSzJHNmpLT3VSV3RNS3M3X2ZldWZNRGM4My1QYnNTRVI5WHRybDhfVll4OVdJTFpZUEpNdUZtRTVHVC1ORWFpanRUZmI1bTE0?oc=5", "source_name": "Market source", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Stocks Q1 Highlights: Haemonetics (NYSE:HAE)", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNMTBnNnM2WGg4UWl4LXNNdUdWLVozU3ptQlRZQTk2SFFsOEZTLTVlbU5tNnhSTVRXX3RYczQ5b2hCR254bS1QYmZqV2JfdVFYTEx2U0hFeW1VREwybmRDWEE3MEpSWldySDJNTHFXbWcta2tNY0cwM0hVWld5VnVOWE1zY1VNQS1wQkIyZHN5a0dRNktDdnBvaTcyY3RKa292aThMTmNGeUpUUVU1Unhr?oc=5", "source_name": "Market source", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Stocks Q1 Teardown: Bausch + Lomb (NYSE:BLCO) Vs The Rest", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPUFI2R08xV3JsZHYxbnFGcmk1Q3prRzBQVVlJNk5NTFlYOXBaczlzZE1PREIxb0loeUNQeUw3QWczNUowYXlEOU1KY1dTY2gybUQ5OEM0Z3Z2TlNleUVIRWJMc0VqZTdZcnVOZ2JBeUpIeFNCVjk3SVYxTmc5SG1RTjBHY2l3QkdxX09lZkpMekpYOElqQmJHc0dHUm8tVzJzSFZRaUdZZzNodTdyRjZz?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos (NYSE: AVNS) director Julie Ann Shimer receives 12,003 restricted units", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPeEtKM0pzNzlsTzBpdlM5SjJadnZMMDNXUHctMkhyUEpTRGRKVXdFRUxDUThKZlkxZzJJeVhqc2FQWWFrSzNyV2JBNzFHZnJ0R3dtSEdrUTcwV3BPT0dFTnVSN25DWFdwVVVZdkZUUUF0UWJPU1Juc1FJY3h6VzNMTVhqek1QdzJFU21YVGxoOXV6cVBqVmp3VjBxUlg1aGJjbmRYbmRJRExEUENuMFZUM0FR?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Deciphering Avanos Medical (AVNS) International Revenue Trends", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxOQlZWQVBvd0VxNUx0cW1nYjVXV3VtQ2M5eGo1T013SE4ydWpmTGVSNUtUNnRheGZGUGJ5V21qTmdJNkJGU3F4dmN1a01WREFIenVNSWZmaC1odzVRUUt6Mml6SGd5VlJhOEZib19qS0ZNMmpNVG1FdUF2aElRbGJXWG1kSmdOSjJrRUZ2YUVEVUp0bVlrZGhlaW9LZEhMZENIUi0yVWpFVU5jLXkteFBv?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos Medical, Inc. Announces First Quarter 2026 Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxOOXZxY1hNdl83dThQaEM4X1NDeEVySlB6M0kycXBxS1g1cGtwQ1BPWWNmYkl2QUdRU1F2X3NjRFpOTi1yZXFpajBMbGE2cTloOGJfclNFUW9va0pQelB6Y0htdUgzUThtMWZFckVfaGdJV0tfZG54TVRTOGxEQl9xd1ozdVJGOXpDbUFIaDNiaU5tUXRwV2NhSlRBcFN5NThTeE0zREstSjQ3MEVYbXRHdg?oc=5", "source_name": "PR Newswire", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Too Late To Consider Buying Avanos Medical (AVNS) After Its Recent Share Price Surge?", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNQTA1WEZFR1pSeGRQQ1lnZGNtQTNkeTZhZWJnRkl5cWltNEZLbk9jal9PdkJleVFqVkhRUS05bGtKLU51VUNqcDVvVXU3cUVyRmFDTGRvV3RIa3FVUEJxVzhtUnItYk8xb3FZTWoyeVVsdHN0Qm43TkJoa2FSc0IwaEhjak5JdVBWMGkzUTF3TzFKZFU1S2E2amFVbXdfaHJX?oc=5", "source_name": "Market source", "published_at": "2026-04-19T07:00:00+00:00", "published_display": "19 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos Medical Stock Looks Capped After American Industrial Partners' Offer (NYSE:AVNS)", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxOeUVYaTlub2NUMUJ3dDhmVWxETWVjTnpHb3Y1VTR1Mnlod0FnczhnTXltcXA5d0ExNjBTYk41UFFwWE9GNi1DUGpkZ2VhVzFzVzRkTnoySnBHeWZpZjEtVnl0N2M4TFRiRUN4Nk9WblVzNmVaUmdhM0ZaWm85blg0YTgyT0FLSzdGM2NYSHh0TTk1OTVVZ3h0cHhWTWZvTWs1SkNqQWs0X0dYQ0dvby1XWUMzRFJLZw?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-15T07:00:00+00:00", "published_display": "15 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos Stock Surged on $1.27 Billion AIP Buyout Deal at 72% Premium", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxNU3docHR1VGFsZ0xXSkMyVUh3bkxZUGtxQ2tqRm12b05HZlBMM2w5RVNOX0tTMVFVSjJCLUw0TjBCdXU4ZXJBY0laVlhwcVROZEEwOUxRYndXVHctdEJaWEZiVS16N3Qxc0pWaDdQSkVRSms1OGRva25xRm4tUmQ2N1l3cXRBaGRRZDIwdmw3amNhMkk?oc=5", "source_name": "Market source", "published_at": "2026-04-15T07:00:00+00:00", "published_display": "15 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVNS Stock Records Historic Intraday Surge \u2013 Everything To Know About The Buyout Deal By American Industrial Partners", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwJBVV95cUxOTm1td0N4eHVnQ05mOFJFN2RlbmxMVVdLbHZkeTQ5d0VReWhmNTZxZ2xpdzMzaWJWUWkwbVpKbEh4SUI1NmZYR085RHVjSzhNQnNuYWNBd3paa0ZGYWV0c3lwTE1tcUNPWEJvUk9JY0d4bDdWLV83SDVuVlpmN2dQMTBIVUg0LTJJRzNWWWR3bXM3TUQtblcxdjNNazBVLUdWOWRjWWUwcm5CN2pEV0hSWUxIdGtxWTBPQzN4bDhxUWwza1JYZk1nTG1OUXJMekU4THVHTEVINnNWV1Fsbm0zZ2QzSGxXQ0ZpQjQwUmk5UFlfeW94SkxLWHdyZm5FSDQ4N3F4dWZfNjBudzg?oc=5", "source_name": "Stocktwits", "published_at": "2026-04-14T07:00:00+00:00", "published_display": "14 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos Medical, Inc. Agrees To Be Acquired by American Industrial Partners for Approximately $1.272 Billion", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8gFBVV95cUxPSDB5Qko3Znd3ZnUxbFVZZWR4eTNQNTM2aW54SWVMOVlXSFFVMWFCS2dTd1BrV3NreEtUMmwwOHpJVG92V0ZYMUFjUndHMk9zcXRQNFEwY2lpUWZOdFlSTDBnd3lxM2dTT0dyQ3ROTGZlOFltbkY4SDJQemhQQnhVR09zTUNGVXV1YUM0emc5eGlQMTBDZExvMXFVZWUtOU1aYng1bE82ejJZM3VHc180dVNSbDNCMEYzUm1xWl9JZkpPUnVmbVNuSTIxRlgxU25NaUYyVkl2R2hYY1lmeXFuNHlVY3h0YTRTenU4T3NMcjAxQQ?oc=5", "source_name": "PR Newswire", "published_at": "2026-04-14T07:00:00+00:00", "published_display": "14 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AIP to take Avanos (NYSE: AVNS) private at $25 per share", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxQWGRvQ243WE9DWmM2cXVMLXlTWExvSkNBRkFxOG5VY1JQUHZpa201a3M5RkNObG5GVnpKb0NvMmZZS292bjlhaXE5MFBweGNtMG5NZVpFLWpfODVOZG5OeGludzZKczRjdl9YTkVzYmxjME5GcHFJLXA4M1o1ai1KekJ5eGhiZ29scHhlNE56eTlLbU5LMGxWVDNvR2hhZTJzRG9HNl9xSkVDdFU?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-14T07:00:00+00:00", "published_display": "14 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos Medical to go private in $1.27B acquisition by AIP", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQOHpfdFUtSEpmNmN4T3AzOGJDSDBkZlJ4OHpyUEpnd0cxbHY2d0I2UUVhVkp0SV8xeU9abldpLWxweDA4S2tPMmRNUUVmdUhCT3ZRTzdQNmxJYk9xVHF1bzF0RFdiNEVoWjE1ZnFQTTNhQ1htbllma3czd1ZLVWNiSFdlVEtHMU9kS1pTNUxFcTI5dlA2MXRCRklPNmE?oc=5", "source_name": "BioWorld News", "published_at": "2026-04-14T07:00:00+00:00", "published_display": "14 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos Medical jumps on $25-per-share take-private agreement | AVNS Stock News", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxOTjllQWZrN05UdDU4bmVRTUN3eWxZM1VZUFAyZVNSX3BDeDUta24wdGtSeGJXMnkyd3dqcHM4YkhmZHh4NE5PRnoxa0kxZFlqdnFPTzVSUEVlLWZ2dGtYSDRhZ1pUYWZpMDJSc3dvZUtTeS15c0pya2FFWHh3YzU5aGF1YXNydk12OTVGakxuRTNjcVRmUFNpaDF4bw?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-04-14T07:00:00+00:00", "published_display": "14 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVANOS MEDICAL, INC. ($AVNS) CEO 2025 Pay Revealed", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxQLWRGbXR3T1YzcXpBMkVKQlVReXpnMEs1ZER0a2tTT3pVWmNwZlJuaHZNclVqSEw4VWN1SmxoY3lzSU5MSzE5OXNyaXdmejZYZ0JIQzJySmZBM0ZmLXRjYmkwblRlVjJPQ2I4TVRQM3p2MnhDZUpxRXRfOGJzMGE4SjhSRThobjg0cU5vMlAydnl6eGNGUkE?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-03-13T07:00:00+00:00", "published_display": "13 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Avanos to supplement proxy after shareholder suits; J.P. Morgan valuation range cited", "summary": "Avanos will voluntarily supplement its definitive proxy statement due to shareholder lawsuits alleging disclosure deficiencies related to its pending $25.00-per-share merger. The company denies the allegations, stating the supplement aims to avoid litigation delays and costs, wit", "url": "https://www.tradingview.com/news/tradingview:da4dca19c1ae3:0-avanos-to-supplement-proxy-after-shareholder-suits-j-p-morgan-valuation-range-cited/", "source_name": "TradingView", "published_at": "2026-07-15T09:47:32", "published_display": "15 Jul 2026 09:47", "sentiment": "negative", "sentiment_pct": 38, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Avanos Medical, Inc. \u2013 MUN:8HH", "summary": "This article displays the \"Price to earnings forward\" metric for Avanos Medical, Inc. (MUN:8HH) on the TradingView platform. The content primarily shows navigation and interface elements of the TradingView site, with the specific financial data point itself being \"Period Value Ch", "url": "https://www.tradingview.com/symbols/MUN-8HH/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-10T06:09:21", "published_display": "10 Jul 2026 06:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Latham Advises on Financing for American Industrial Partners\u2019 US$1.272 Billion Acquisition of Avanos Medical, Inc.", "summary": "Latham & Watkins LLP represented the financing sources for American Industrial Partners' (AIP) acquisition of Avanos Medical, Inc., a medical technology company. AIP acquired Avanos in an all-cash transaction valued at approximately US$1.272 billion. The Latham team involved part", "url": "https://www.lw.com/en/news/2026/07/latham-advises-on-financing-for-american-industrial-partners-acquisition-of-avanos-medical-inc", "source_name": "Latham & Watkins LLP", "published_at": "2026-07-09T00:10:38", "published_display": "09 Jul 2026 00:10", "sentiment": "positive", "sentiment_pct": 70, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Has Avanos Medical (AVNS) Run Ahead Of Fundamentals On Its Russell Index Removal?", "summary": "Avanos Medical (AVNS) was recently removed from the Russell 2000 Defensive and Value-Defensive Indexes, which can impact institutional trading. Despite this, AVNS has seen significant recent share price gains of 79.02% over 90 days and 122.90% year-to-date. The article questions ", "url": "https://simplywall.st/stocks/us/healthcare/nyse-avns/avanos-medical/news/has-avanos-medical-avns-run-ahead-of-fundamentals-on-its-rus", "source_name": "Simply Wall Street", "published_at": "2026-07-09T00:10:17", "published_display": "09 Jul 2026 00:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos Medical (AVNS) Q4 2024 earnings summary", "summary": "Avanos Medical (AVNS) reported strong Q4 and full-year 2024 performance, driven by growth in Enteral Feeding and the divestiture of its respiratory health business. Despite a net loss due to a non-cash impairment charge, the company achieved significant increases in adjusted dilu", "url": "https://quartr.com/events/avanos-medical-inc-avns-q4-2024_on8vL18K", "source_name": "Quartr", "published_at": "2026-07-08T13:11:14", "published_display": "08 Jul 2026 13:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Avanos Medical, Inc. \u2013 LS:A2JNRG", "summary": "This article provides financial data for Avanos Medical, Inc. (LS:A2JNRG) focusing on its Enterprise Value to EBIT forward ratio. It highlights the availability of financial figures and market data for the company through TradingView, noting that the market is currently closed.", "url": "https://www.tradingview.com/symbols/LS-A2JNRG/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-07-07T15:39:55", "published_display": "07 Jul 2026 15:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos Medical (AVNS) Q1 2026 earnings summary", "summary": "Avanos Medical announced its Q1 2026 earnings, reporting net sales of $182.2 million, an 8.8% increase year-over-year, driven by strong growth in Specialty Nutrition Systems. The company also announced a definitive agreement to be acquired by affiliates of American Industrial Par", "url": "https://quartr.com/events/avanos-medical-inc-avns-q1-2026_on8v3hZe", "source_name": "Quartr", "published_at": "2026-07-07T12:09:21", "published_display": "07 Jul 2026 12:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Avanos Medical, Inc. \u2013 LS:A2JNRG", "summary": "This article focuses on the enterprise value to revenue forward for Avanos Medical, Inc. (LS:A2JNRG). It appears to be a financial data point from TradingView, indicating a key valuation metric for the company. The content primarily highlights this specific financial metric witho", "url": "https://www.tradingview.com/symbols/LS-A2JNRG/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-07T10:10:54", "published_display": "07 Jul 2026 10:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos stock stays tied to medical devices.", "summary": "Avanos Medical Inc (ISIN US05350V1061) is a Nasdaq-listed medical device company specializing in chronic care, pain management, and digestive health products. The company's business model relies on its portfolio of infection prevention, chronic care, and interventional products, ", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/avanos-stock-stays-tied-to-medical-devices/69707128", "source_name": "AD HOC NEWS", "published_at": "2026-07-06T16:10:34", "published_display": "06 Jul 2026 16:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos Medical advances toward AIP-led go-private merger", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxQNWJyc2xEZXdDZXRHamJ6eGhiNXNzcHAzeGViUDAyVnd1TmNycTcyWXc1emQya0d4SmhMMkt4TTNwQVB6LXVOal81RE1ZRUJNNDduai1iV3F1OE83ajdtWXdSZ2NPSnFPSmt1Q1B0bnpobzdVcEpKcGQ3UE5RNGtwVkpOalJMWjVTcHc2S05OZWJkSjdHTHZyS3BqZ0ptblF4bnlSS0VYRzJPUzFSYTliT3N2MDUwZFRWNzdWRFBpWlVYTy0tSzVuSTl3LUQtSTFPcGdn?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-07-03T14:42:00+00:00", "published_display": "03 Jul 2026 14:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos, American Industrial Get Regulatory Approval for Merger", "summary": "Avanos and American Industrial have received regulatory approval for their merger. This development marks a significant step forward for the two companies as they proceed with their integration plans.", "url": "https://www.moomoo.com/news/post/72407474/avanos-american-industrial-get-regulatory-approval-for-merger", "source_name": "Moomoo", "published_at": "2026-07-03T10:10:05", "published_display": "03 Jul 2026 10:10", "sentiment": "positive", "sentiment_pct": 71, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVANOS MEDICAL INC (AVNS) Stock Chart", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZEFVX3lxTE5LUHI0Uk9uZzJ0N3JvdTJLc3BiMnlLT1RtRE5laXdRZjBjX1JKUDFJSDRaZzl6UTBsU281ck5rSE5mczN1cGMyUlBtZEpQTzRqN09xUjNVaVhucENkVnhWX2N5NDg?oc=5", "source_name": "ChartMill", "published_at": "2026-07-03T00:18:39+00:00", "published_display": "03 Jul 2026 00:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos Medical, Inc. and American Industrial Partners Receive Required Regulatory Approvals for Pending Merger", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/avanos-medical-inc-american-industrial-140000118.html", "source_name": "PR Newswire", "published_at": "2026-07-02T14:00:00+00:00", "published_display": "02 Jul 2026 14:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos Medical, American Industrial Partners Clear Regulatory Hurdle for Merger", "summary": "Avanos Medical Inc. and American Industrial Partners (AIP) have received all necessary regulatory approvals for AIP's acquisition of Avanos Medical, moving the deal closer to its projected completion later this month. The merger, valued at approximately $2.2 billion, is now subje", "url": "https://www.citybiz.co/article/869447/avanos-medical-american-industrial-partners-clear-regulatory-hurdle-for-merger/", "source_name": "citybiz", "published_at": "2026-07-02T14:39:26", "published_display": "02 Jul 2026 14:39", "sentiment": "positive", "sentiment_pct": 71, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 96, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos receives regulatory approvals, merger expected to close by July 27 pending shareholder vote", "summary": "Avanos (AVNS) has secured all necessary regulatory approvals for its acquisition by affiliates of American Industrial Partners. The merger is anticipated to finalize by July 27, 2026, contingent on shareholder approval. A special stockholder meeting for Avanos to vote on the merg", "url": "https://www.tradingview.com/news/tradingview:6de122e513bd7:0-avanos-receives-regulatory-approvals-merger-expected-to-close-by-july-27-pending-shareholder-vote/", "source_name": "TradingView", "published_at": "2026-07-02T14:39:26", "published_display": "02 Jul 2026 14:39", "sentiment": "positive", "sentiment_pct": 67, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 96, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos Medical stock holds its focus on procedure demand", "summary": "Avanos Medical (AVNS) focuses on procedure demand within its US medtech footprint, with its stock performance tied to hospital and outpatient spending trends. The company, which trades on the NYSE, specializes in products for pain management, digestive health, and respiratory car", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/avanos-medical-stock-holds-its-focus-on-procedure-demand/69672323", "source_name": "AD HOC NEWS", "published_at": "2026-07-02T11:39:26", "published_display": "02 Jul 2026 11:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Avanos Medical (AVNS) Undervalued Or Has Its Strong Run Already Priced In?", "summary": "Avanos Medical (AVNS) has seen significant stock performance despite recent net losses and declining longer-term returns. The company's current Price-to-Sales (P/S) multiple of 1.6x is below industry and peer averages, suggesting a discount, but is above an estimated fair P/S rat", "url": "https://www.sahmcapital.com/news/content/is-avanos-medical-avns-undervalued-or-has-its-strong-run-already-priced-in-2026-06-30", "source_name": "Sahm", "published_at": "2026-07-01T22:40:44", "published_display": "01 Jul 2026 22:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Avanos Medical, Inc. \u2013 LS:A2JNRG", "summary": "This article displays the forward price-to-sales ratio for Avanos Medical, Inc. (LS:A2JNRG) on TradingView. It indicates that the market was closed at the time of viewing, with no trades having occurred. The page provides an overview of financial data for the company.", "url": "https://www.tradingview.com/symbols/LS-A2JNRG/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-01T08:09:46", "published_display": "01 Jul 2026 08:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos Medical with steady outlook, shares tracked against medtech peers", "summary": "Avanos Medical is focused on single-use medical devices and is situated within a consolidating medtech sector, with its shares tracked against competitors like Medtronic and Boston Scientific. Analysts generally hold a moderate upside view on AVNS shares, focusing on the company'", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/avanos-medical-with-steady-outlook-shares-tracked-against-medtech-peers/69655500", "source_name": "AD HOC NEWS", "published_at": "2026-06-29T20:41:09", "published_display": "29 Jun 2026 20:41", "sentiment": "positive", "sentiment_pct": 60, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos Medical, Inc.(NYSE: AVNS) dropped from Russell 2000 Defensive Index", "summary": "Avanos Medical, Inc. (NYSE: AVNS) has been removed from the Russell 2000 Defensive Index. This news follows several recent updates for the company, including first-quarter earnings results and an announcement of its acquisition by American Industrial Partners for $1.27 billion. A", "url": "https://www.marketscreener.com/news/avanos-medical-inc-nyse-avns-dropped-from-russell-2000-defensive-index-ce7f5fded881f424", "source_name": "www.marketscreener.com", "published_at": "2026-06-28T20:52:03", "published_display": "28 Jun 2026 20:52", "sentiment": "negative", "sentiment_pct": 39, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos Medical, Inc. Actuals & Estimates (NYSE:AVNS)", "summary": "This article provides an overview of Avanos Medical, Inc. (NYSE:AVNS) stock's financial performance, including actuals and estimates for income, balance sheet, and cash flow. It details current stock price, historical highs and lows, market capitalization, and upcoming earnings r", "url": "https://www.tradingview.com/symbols/NYSE-AVNS/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T12:40:58", "published_display": "26 Jun 2026 12:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVNS - Avanos Medical Inc Latest SEC Filings", "summary": "This article provides detailed financial data and market performance metrics for Avanos Medical Inc (AVNS), including its stock price, market capitalization, income, sales, and various financial ratios. It also lists key dates, such as IPO and earnings, along with insider and ins", "url": "https://finviz.com/stock?t=AVNS&ta=1&p=d&ty=lf&b=1", "source_name": "Finviz", "published_at": "2026-06-25T21:39:26", "published_display": "25 Jun 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Avanos Medical, Inc. \u2013 BOATS:AVNS", "summary": "This article provides the \"Price to earnings forward\" metric for Avanos Medical, Inc. (AVNS) on the Blue Ocean Alternative Trade System (BOATS) platform. It indicates that the market is closed, with no trades currently available for the stock. The content is primarily a listing o", "url": "https://www.tradingview.com/symbols/BOATS-AVNS/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T15:10:58", "published_display": "25 Jun 2026 15:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spotting Winners: Merit Medical Systems (NASDAQ:MMSI) And Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks In Q1", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPZ3VmWDdGZC04R2RXUUJZTHJqVlJrdnhJYy1LaEJkcHBaWi1sWXdoWS1oLWFlVUQxdFNOQlNDdzhaTHJtMGRkX3pHc1pWbGp0bENwY1h6TlpvWVRWWmJxODh4emhGVDBFajd0VWNmUGNVcnN1SDBXRG9jZFVDa2M4MGFCVFhxbGN0ZXZqSTV2SUE1S3JjMTRnQlBiSnVmR0lv?oc=5", "source_name": "Market source", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price-Driven Insight from (AVNS) for Rule-Based Strategy", "summary": "This article provides a price-driven insight into Avanos Medical Inc. (AVNS) for rule-based trading strategies. It highlights neutral near and mid-term readings but a strong long-term positive bias, noting that resistance is being tested. The analysis details institutional tradin", "url": "https://news.stocktradersdaily.com/news_release/101/Price-Driven_Insight_from_AVNS_for_Rule-Based_Strategy_062426104202_1782355322.html", "source_name": "Stock Traders Daily", "published_at": "2026-06-24T22:42:00", "published_display": "24 Jun 2026 22:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos Medical Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avanos Medical, Inc. - AVNS", "summary": "Kahn Swick & Foti, LLC (KSF) is investigating the proposed sale of Avanos Medical, Inc. (NYSE: AVNS) to affiliates of American Industrial Partners. KSF is scrutinizing the $25.00 per share cash offer to determine if it adequately values the company and if the sales process was fa", "url": "https://www.businesswire.com/news/home/20260624050462/en/Avanos-Medical-Investor-Alert-Kahn-Swick-Foti-LLC-Investigates-Adequacy-of-Price-and-Process-in-Proposed-Sale-of-Avanos-Medical-Inc.---AVNS", "source_name": "Business Wire", "published_at": "2026-06-24T19:09:49", "published_display": "24 Jun 2026 19:09", "sentiment": "negative", "sentiment_pct": 37, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reasons to Retain Avanos Medical Stock in Your Portfolio for Now", "summary": "Avanos Medical (AVNS) is well-positioned for growth due to its strong product line, particularly in Specialty Nutrition Systems, and strategic acquisitions like Nexus Medical, despite challenges from tariff risks and weaknesses in its Pain Management & Recovery business. The comp", "url": "https://uk.finance.yahoo.com/news/reasons-retain-avanos-medical-stock-134700828.html", "source_name": "Market source", "published_at": "2026-06-24T13:47:00", "published_display": "24 Jun 2026 13:47", "sentiment": "positive", "sentiment_pct": 61, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos Medical Inc (AVNS) Institutional Confidence", "summary": "Avanos Medical Inc (AVNS) has an institutional shareholding score of 10.00, placing it first in the Healthcare Equipment & Supplies industry. This score reflects a 97.19% institutional shareholding proportion, although this represents a 14.66% decrease quarter-over-quarter. Diamo", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-avns/sentiment", "source_name": "TradingKey", "published_at": "2026-06-24T06:39:47", "published_display": "24 Jun 2026 06:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Undervalued Medical-Devices Stock Is Poised for a Rebound", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPN1g2RjVsUTVvTmdXRTdJMTRpVTlOQnZIbm9hTWJDdkRaeVpINjFqbXpDUVFpMVdYMExyR2VQQVNpZ3p0V2F1SVJMelpJZWk1bExvb0dYWnJ4VVJJRURseEVQVVZwNnRZREZiQzlFTHlhSHFadGdXRmpxbXA2XzBMNA?oc=5", "source_name": "Barron's", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos Medical Stock - Long-term strategy in focus for medtech specialist", "summary": "Avanos Medical focuses on single-use medical devices for pain management and minimally invasive care. The article highlights the company's long-term strategy, portfolio mix, and market positioning against larger medtech competitors. It also discusses Avanos's revenue drivers, cap", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/avanos-medical-stock-long-term-strategy-in-focus-for-medtech-specialist/69592941", "source_name": "AD HOC NEWS", "published_at": "2026-06-20T19:10:37", "published_display": "20 Jun 2026 19:10", "sentiment": "positive", "sentiment_pct": 63, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos Medical Inc (AVNS) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "Avanos Medical Inc (AVNS) has an earnings forecast score of 6.00, placing it 172nd in its industry, with an average analyst price target of $14.00. One analyst currently rates the stock as \"Hold\". The company's expected revenue for the next quarter is $173.00 million, and its EPS", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-avns/earnings", "source_name": "TradingKey", "published_at": "2026-06-18T09:10:34", "published_display": "18 Jun 2026 09:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos Medical Inc (AVNS) Financial Health: Profitability & Balance Sheet Analysis", "summary": "Avanos Medical Inc (AVNS) has a strong financial health score of 7.17, ranking 104 out of 204 in its industry. The company demonstrated robust operating efficiency with a year-over-year revenue increase of 8.78% to $182.20M and a net profit increase of 22.73%. This analysis highl", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-avns/financial-health", "source_name": "TradingKey", "published_at": "2026-06-17T22:10:35", "published_display": "17 Jun 2026 22:10", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spotting Winners: Enovis (NYSE:ENOV) And Medical Devices & Supplies - Specialty Stocks In Q1", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQRWNsVUM3aGV5UmJHYUowOWtNRU11RzZSalpyampRQ3ZQTlBNV05zSHo4MTJJS0JqTV92LWV3MUdXWkRIckNNZi1aeVg1TmtKNFpoS3g5dTBXRW1BZXRMWGo1SVl2NjNaQ2NSNV90V0MtMzBEQndVclZzUUVXbi1FU0lyU0FndlAwaXNfUVpOTXBEZWQtQVpmanRoU0JjLWxlakFJSQ?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At Avanos Medical (AVNS) Valuation After Recent 3 Month Share Price Surge", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNdXpRaVFkdXV4UlhHbFBUcS1BYTdqS3lzY1d3QnZzNTJWNGs5ZWQ5Mm9fUi1mYUlib3BvQ3I5cV9hNE1yQXViOGpWeE83QkhDY3cwaExjU2hTOTExN01QRHRMV0tvODQ4cVN0NWNVM3BGdFlhcFdxaWp3bWtGaFh3c0dlQ2V6MTE3cmVGTVhTbTJ3Y01aQmFTRDVkMXRpZjA4?oc=5", "source_name": "Market source", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos Medical (AVNS) Up 1.1% Since Last Earnings Report: Can It Continue?", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxNakY5bm9uT1lVNGNfX2lUZXc1cHBNZUlzWXgycGpmXzRMOTVJVEhnbHZ5VzRFd3FBS0pHSm0yZjJVZU5HWlNTR1V1THJVQnpXUi01Yi1PNFhRVF80VzVOQlY1TzRlcXFGcWxPWlhnQy15N3VEMDhnMVlXZUN2Q1ZMVUtGMnN2dzRzNmxBa1lEMU1Pdw?oc=5", "source_name": "Market source", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spotting Winners: Boston Scientific (NYSE:BSX) And Medical Devices & Supplies - Diversified Stocks In Q1", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQV2pTUXRCTjY5SmdHMUhoekd1YmdUMW44R1VVYVlZZzh6QzB1VDZqSzJXT1RLOWpZeE16cGVfaVU3bUFsZ0g5OUkyRlpmQjUxUGw0eDAyb3oySURyM2taYm5qeWZRSzJHNmpLT3VSV3RNS3M3X2ZldWZNRGM4My1QYnNTRVI5WHRybDhfVll4OVdJTFpZUEpNdUZtRTVHVC1ORWFpanRUZmI1bTE0?oc=5", "source_name": "Market source", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Stocks Q1 Highlights: Haemonetics (NYSE:HAE)", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNMTBnNnM2WGg4UWl4LXNNdUdWLVozU3ptQlRZQTk2SFFsOEZTLTVlbU5tNnhSTVRXX3RYczQ5b2hCR254bS1QYmZqV2JfdVFYTEx2U0hFeW1VREwybmRDWEE3MEpSWldySDJNTHFXbWcta2tNY0cwM0hVWld5VnVOWE1zY1VNQS1wQkIyZHN5a0dRNktDdnBvaTcyY3RKa292aThMTmNGeUpUUVU1Unhr?oc=5", "source_name": "Market source", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Stocks Q1 Teardown: Bausch + Lomb (NYSE:BLCO) Vs The Rest", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPUFI2R08xV3JsZHYxbnFGcmk1Q3prRzBQVVlJNk5NTFlYOXBaczlzZE1PREIxb0loeUNQeUw3QWczNUowYXlEOU1KY1dTY2gybUQ5OEM0Z3Z2TlNleUVIRWJMc0VqZTdZcnVOZ2JBeUpIeFNCVjk3SVYxTmc5SG1RTjBHY2l3QkdxX09lZkpMekpYOElqQmJHc0dHUm8tVzJzSFZRaUdZZzNodTdyRjZz?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos (NYSE: AVNS) director Julie Ann Shimer receives 12,003 restricted units", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPeEtKM0pzNzlsTzBpdlM5SjJadnZMMDNXUHctMkhyUEpTRGRKVXdFRUxDUThKZlkxZzJJeVhqc2FQWWFrSzNyV2JBNzFHZnJ0R3dtSEdrUTcwV3BPT0dFTnVSN25DWFdwVVVZdkZUUUF0UWJPU1Juc1FJY3h6VzNMTVhqek1QdzJFU21YVGxoOXV6cVBqVmp3VjBxUlg1aGJjbmRYbmRJRExEUENuMFZUM0FR?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Deciphering Avanos Medical (AVNS) International Revenue Trends", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxOQlZWQVBvd0VxNUx0cW1nYjVXV3VtQ2M5eGo1T013SE4ydWpmTGVSNUtUNnRheGZGUGJ5V21qTmdJNkJGU3F4dmN1a01WREFIenVNSWZmaC1odzVRUUt6Mml6SGd5VlJhOEZib19qS0ZNMmpNVG1FdUF2aElRbGJXWG1kSmdOSjJrRUZ2YUVEVUp0bVlrZGhlaW9LZEhMZENIUi0yVWpFVU5jLXkteFBv?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos Medical, Inc. Announces First Quarter 2026 Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxOOXZxY1hNdl83dThQaEM4X1NDeEVySlB6M0kycXBxS1g1cGtwQ1BPWWNmYkl2QUdRU1F2X3NjRFpOTi1yZXFpajBMbGE2cTloOGJfclNFUW9va0pQelB6Y0htdUgzUThtMWZFckVfaGdJV0tfZG54TVRTOGxEQl9xd1ozdVJGOXpDbUFIaDNiaU5tUXRwV2NhSlRBcFN5NThTeE0zREstSjQ3MEVYbXRHdg?oc=5", "source_name": "PR Newswire", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Too Late To Consider Buying Avanos Medical (AVNS) After Its Recent Share Price Surge?", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNQTA1WEZFR1pSeGRQQ1lnZGNtQTNkeTZhZWJnRkl5cWltNEZLbk9jal9PdkJleVFqVkhRUS05bGtKLU51VUNqcDVvVXU3cUVyRmFDTGRvV3RIa3FVUEJxVzhtUnItYk8xb3FZTWoyeVVsdHN0Qm43TkJoa2FSc0IwaEhjak5JdVBWMGkzUTF3TzFKZFU1S2E2amFVbXdfaHJX?oc=5", "source_name": "Market source", "published_at": "2026-04-19T07:00:00+00:00", "published_display": "19 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos Medical Stock Looks Capped After American Industrial Partners' Offer (NYSE:AVNS)", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxOeUVYaTlub2NUMUJ3dDhmVWxETWVjTnpHb3Y1VTR1Mnlod0FnczhnTXltcXA5d0ExNjBTYk41UFFwWE9GNi1DUGpkZ2VhVzFzVzRkTnoySnBHeWZpZjEtVnl0N2M4TFRiRUN4Nk9WblVzNmVaUmdhM0ZaWm85blg0YTgyT0FLSzdGM2NYSHh0TTk1OTVVZ3h0cHhWTWZvTWs1SkNqQWs0X0dYQ0dvby1XWUMzRFJLZw?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-15T07:00:00+00:00", "published_display": "15 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos Stock Surged on $1.27 Billion AIP Buyout Deal at 72% Premium", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxNU3docHR1VGFsZ0xXSkMyVUh3bkxZUGtxQ2tqRm12b05HZlBMM2w5RVNOX0tTMVFVSjJCLUw0TjBCdXU4ZXJBY0laVlhwcVROZEEwOUxRYndXVHctdEJaWEZiVS16N3Qxc0pWaDdQSkVRSms1OGRva25xRm4tUmQ2N1l3cXRBaGRRZDIwdmw3amNhMkk?oc=5", "source_name": "Market source", "published_at": "2026-04-15T07:00:00+00:00", "published_display": "15 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVNS Stock Records Historic Intraday Surge \u2013 Everything To Know About The Buyout Deal By American Industrial Partners", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwJBVV95cUxOTm1td0N4eHVnQ05mOFJFN2RlbmxMVVdLbHZkeTQ5d0VReWhmNTZxZ2xpdzMzaWJWUWkwbVpKbEh4SUI1NmZYR085RHVjSzhNQnNuYWNBd3paa0ZGYWV0c3lwTE1tcUNPWEJvUk9JY0d4bDdWLV83SDVuVlpmN2dQMTBIVUg0LTJJRzNWWWR3bXM3TUQtblcxdjNNazBVLUdWOWRjWWUwcm5CN2pEV0hSWUxIdGtxWTBPQzN4bDhxUWwza1JYZk1nTG1OUXJMekU4THVHTEVINnNWV1Fsbm0zZ2QzSGxXQ0ZpQjQwUmk5UFlfeW94SkxLWHdyZm5FSDQ4N3F4dWZfNjBudzg?oc=5", "source_name": "Stocktwits", "published_at": "2026-04-14T07:00:00+00:00", "published_display": "14 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos Medical, Inc. Agrees To Be Acquired by American Industrial Partners for Approximately $1.272 Billion", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8gFBVV95cUxPSDB5Qko3Znd3ZnUxbFVZZWR4eTNQNTM2aW54SWVMOVlXSFFVMWFCS2dTd1BrV3NreEtUMmwwOHpJVG92V0ZYMUFjUndHMk9zcXRQNFEwY2lpUWZOdFlSTDBnd3lxM2dTT0dyQ3ROTGZlOFltbkY4SDJQemhQQnhVR09zTUNGVXV1YUM0emc5eGlQMTBDZExvMXFVZWUtOU1aYng1bE82ejJZM3VHc180dVNSbDNCMEYzUm1xWl9JZkpPUnVmbVNuSTIxRlgxU25NaUYyVkl2R2hYY1lmeXFuNHlVY3h0YTRTenU4T3NMcjAxQQ?oc=5", "source_name": "PR Newswire", "published_at": "2026-04-14T07:00:00+00:00", "published_display": "14 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AIP to take Avanos (NYSE: AVNS) private at $25 per share", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxQWGRvQ243WE9DWmM2cXVMLXlTWExvSkNBRkFxOG5VY1JQUHZpa201a3M5RkNObG5GVnpKb0NvMmZZS292bjlhaXE5MFBweGNtMG5NZVpFLWpfODVOZG5OeGludzZKczRjdl9YTkVzYmxjME5GcHFJLXA4M1o1ai1KekJ5eGhiZ29scHhlNE56eTlLbU5LMGxWVDNvR2hhZTJzRG9HNl9xSkVDdFU?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-14T07:00:00+00:00", "published_display": "14 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos Medical to go private in $1.27B acquisition by AIP", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQOHpfdFUtSEpmNmN4T3AzOGJDSDBkZlJ4OHpyUEpnd0cxbHY2d0I2UUVhVkp0SV8xeU9abldpLWxweDA4S2tPMmRNUUVmdUhCT3ZRTzdQNmxJYk9xVHF1bzF0RFdiNEVoWjE1ZnFQTTNhQ1htbllma3czd1ZLVWNiSFdlVEtHMU9kS1pTNUxFcTI5dlA2MXRCRklPNmE?oc=5", "source_name": "BioWorld News", "published_at": "2026-04-14T07:00:00+00:00", "published_display": "14 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avanos Medical jumps on $25-per-share take-private agreement | AVNS Stock News", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxOTjllQWZrN05UdDU4bmVRTUN3eWxZM1VZUFAyZVNSX3BDeDUta24wdGtSeGJXMnkyd3dqcHM4YkhmZHh4NE5PRnoxa0kxZFlqdnFPTzVSUEVlLWZ2dGtYSDRhZ1pUYWZpMDJSc3dvZUtTeS15c0pya2FFWHh3YzU5aGF1YXNydk12OTVGakxuRTNjcVRmUFNpaDF4bw?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-04-14T07:00:00+00:00", "published_display": "14 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AVANOS MEDICAL, INC. ($AVNS) CEO 2025 Pay Revealed", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxQLWRGbXR3T1YzcXpBMkVKQlVReXpnMEs1ZER0a2tTT3pVWmNwZlJuaHZNclVqSEw4VWN1SmxoY3lzSU5MSzE5OXNyaXdmejZYZ0JIQzJySmZBM0ZmLXRjYmkwblRlVjJPQ2I4TVRQM3p2MnhDZUpxRXRfOGJzMGE4SjhSRThobjg0cU5vMlAydnl6eGNGUkE?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-03-13T07:00:00+00:00", "published_display": "13 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 99, "total_relevant": 69, "sentiment_summary": {"positive": 12, "negative": 3, "neutral": 54, "score": 53, "total": 69, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 75, "events": [{"event": "general", "label": "Market update", "weight": 16.65, "count": 29}, {"event": "earnings", "label": "Earnings", "weight": 13.75, "count": 25}, {"event": "deals", "label": "Deals and strategy", "weight": 6.6, "count": 12}, {"event": "macro", "label": "Macro sensitivity", "weight": 0.55, "count": 1}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}], "positive_events": 12, "negative_events": 3}, "market_context": {"has_market_context": true, "latest_close": 24.93, "latest_week": "2026-07-10", "one_week_move": 0.0, "four_week_move": -0.1, "twelve_week_move": 1.3, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.872111, "market_dynamics_buy_signal": false, "relative_strength": 47.519494, "fair_value_gap": 41.0, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "positive", "expectation_probability": 58.7035, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+0.0% over one week, -0.1% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 50, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 19}, {"label": "TradingView", "count": 8}, {"label": "AD HOC NEWS", "count": 4}, {"label": "PR Newswire", "count": 3}, {"label": "TradingKey", "count": 3}, {"label": "Quartr", "count": 2}, {"label": "Stock Titan", "count": 2}, {"label": "StockStory", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 69}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 29}, {"label": "Earnings", "count": 25}, {"label": "Deals and strategy", "count": 12}, {"label": "Macro sensitivity", "count": 1}, {"label": "Guidance", "count": 1}, {"label": "Balance sheet", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "53/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "75/100 classification confidence."}, {"label": "Company focus", "value": "69", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "2", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+0.0% over one week, -0.1% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Negative", "tone": "negative", "text": "Avanos to supplement proxy after shareholder suits; J.P. Morgan valuation range cited"}], "updated_at": "2026-07-16T15:24:21.056537+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}